A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Status:
Recruiting

Trial end date:
2025-07-01

Target enrollment:

Participant gender:

The main purpose of this study is to determine the efficacy and safety of LY3972406 in adult participants with moderate-to-severe plaque psoriasis.

Phase 2

Eli Lilly and Company